Vectus Biosystems progresses its human trials with lead cardiovascular drug candidate VB0004
Vectus Biosystems (ASX: VBS) non-executive director Maurie Stang joins Small Caps to discuss the company’s development of its lead cardiovascular drug VB0004.
A phase 1a human safety trial was successfully completed in Melbourne in September and demonstrated an impressive safety record.
The antifibrotic and antihypertension oral drug will move to the next phase of 1b testing and the company also plans to evaluate its impact in COVID-19 induced fibrotic damage.
Articles:
https://smallcaps.com.au/vectus-biosystems-phase-1b-drug-trial-treat-fibrosis-hypertension/
https://smallcaps.com.au/vectus-biosystems-unveils-more-promising-results-phase-1-clinical-trial/
For more information on Vectus Biosystems:
https://smallcaps.com.au/stocks/VBS/
-----------------------
Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.
-----------------------
WEBSITE
https://smallcaps.com.au/
PODCAST
https://smallcaps.com.au/podcast/
SOCIAL MEDIA
Facebook: https://www.facebook.com/SmallCapsASX
Twitter: https://twitter.com/SmallCapsASX
LinkedIn: https://www.linkedin.com/company/small-caps/
NEWSLETTER
https://smallcaps.com.au/subscribe/
-
23:28
Small Caps
1 year agoInvex Therapeutics rolls-out Evolve phase III trial for drug Presendin in IIH patients
12 -
8:04
Coach Nick Money
10 months agoWill Vistagen Therapeutics Inc $VTGN a Positive Clinical Trial Phase 3 Results Play - Go Parabolic?
-
15:28
Trump Train Pro 🚅 🥇 #Trump2024 #TrumpRally #Mistrial
7 months agoRegulatory specialist unravels COVID-19 vials and clinical trials
364 -
1:25
George4U
1 year agoPresident of the International Vascular Society raises concerns about CoVid Vaccines.
143 -
1:29
Reuters
2 years agoNew AstraZeneca drug 'prevents and treats COVID'
4687 -
34:45
The JD Rucker Show
2 years agoDr Sabine Hazan: How Big Tech is Keeping Ivermectin Researchers From Doing Clinical Trials
59.2K12 -
3:51
Just the News Articles
1 year agoCOVID vax makers finally study long-term heart damage as FDA admits bivalent data lacking
24 -
2:14
pepperpeep
1 year agoA Remarkable Drug: “If You Had to Design a Drug for COVID, It Would Look Exactly Like Ivermectin’
30 -
0:57
Reuters
2 years agoAstraZeneca's sees new COVID-19 drug success
1.2K3 -
1:15
Right Docs of History Via Dr Anthony
1 year agoPresident of the international vascular society raises concerns about covid vaccines
2902